Filtros : "Fonseca, L. Gomes da" Limpar

Filtros



Refine with date range


  • Source: International Journal of Biological Markers. Unidade: FM

    Subjects: POLIMORFISMO, EXPRESSÃO GÊNICA, ASTRÓCITOS (ESTUDO CLÍNICO)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ABREU, A. P. S. et al. Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow. International Journal of Biological Markers, v. 23, n. 4, p. 219-224, 2008Tradução . . Disponível em: https://doi.org/10.5301/jbm.2009.1354. Acesso em: 02 out. 2024.
    • APA

      Abreu, A. P. S., Milani, C., Katayama, M. L. H., Barbosa, K. C., Fonseca, L. G. da, Goes, J. C. S., et al. (2008). Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow. International Journal of Biological Markers, 23( 4), 219-224. doi:10.5301/jbm.2009.1354
    • NLM

      Abreu APS, Milani C, Katayama MLH, Barbosa KC, Fonseca LG da, Goes JCS, Brentani MM, Folgueira MAAK. Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow [Internet]. International Journal of Biological Markers. 2008 ; 23( 4): 219-224.[citado 2024 out. 02 ] Available from: https://doi.org/10.5301/jbm.2009.1354
    • Vancouver

      Abreu APS, Milani C, Katayama MLH, Barbosa KC, Fonseca LG da, Goes JCS, Brentani MM, Folgueira MAAK. Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow [Internet]. International Journal of Biological Markers. 2008 ; 23( 4): 219-224.[citado 2024 out. 02 ] Available from: https://doi.org/10.5301/jbm.2009.1354

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024